Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00595582 · ClinicalTrials.gov registry record · NA
Early Intervention in Mild Cognitive Impairment (MCI) With Curcumin + Bioperine
A NA study, sponsored by Louisiana State University Health Sciences Center Shreveport.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT00595582: Clinical Trial NA study, sponsored by Louisiana State University Health Sciences Center Shreveport.
NCT00595582 is a NA study that was terminated before completion, run by Louisiana State University Health Sciences Center Shreveport. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00595582, a NA study, was terminated before completion, sponsored by Louisiana State University Health Sciences Center Shreveport.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is an additional study to the primary Mild Cognitive Impairment (MCI) study (LSU#H04-049; NCT00243451)that is underway of PET detection of Mild Cognitive Impairment. This study has preliminary data that indicates objective analysis of PET brain image metabolic data is a sensitive marker for AD. The goal of this proposal is to determine the efficacy of curcumin in the treatment of MCI or mild Alzheimer's Disease (AD).
Interventions
- DIETARY_SUPPLEMENT curcumin + bioperine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-05 |
| Est. Completion | 2008-06 |
| Phase | NA |
Why NCT00595582 stopped before completion
NCT00595582 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which curcumin + bioperine is the first listed.
NCT00595582 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00595582 about?
NCT00595582 is a clinical study titled "Early Intervention in Mild Cognitive Impairment (MCI) With Curcumin + Bioperine". This is an additional study to the primary Mild Cognitive Impairment (MCI) study (LSU#H04-049; NCT00243451)that is underway of PET detection of Mild Cognitive Impairment. This study has preliminary data that indicates objective analysis of PET brain image metabolic data is a sensitive marker for AD....
What is the current status of trial NCT00595582?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2005-05. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00595582?
The interventions under investigation include: curcumin + bioperine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00595582?
This trial is sponsored by Louisiana State University Health Sciences Center Shreveport, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00595582's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia